Target intelligence / Profile preview

Extracellular fluid volume and osmolarity (ECFV/Osm)

Target
ECFV/Osm
Molecular classification
Other
01

Overview

Extracellular fluid (ECF) volume and osmolarity are systemic physiological parameters rather than discrete molecular targets. ECF volume is primarily determined by the total body sodium content, which dictates the volume of water retained in the intravascular and interstitial spaces to maintain isotonicity (StatPearls, 2023, Physiology, Osmolarity). Osmolarity refers to the concentration of solutes in the plasma, which is tightly regulated by the hypothalamus and the posterior pituitary through the release of antidiuretic hormone (ADH) acting on renal aquaporins (NIH, 2022, Water and Sodium Balance). While not a single receptor or enzyme, these parameters are the primary therapeutic endpoints for drugs like diuretics, vasopressin antagonists, and intravenous fluids used to treat conditions such as heart failure, hypertension, and dysnatremias. Proper management of these states is essential for maintaining cardiovascular stability and preventing cellular dysfunction, particularly in the central nervous system (Wikipedia, 2024, Osmoregulation).

Other names
Plasma volumeExtracellular fluid balanceSerum osmolarityFluid and electrolyte balanceWater-sodium homeostasis
02

Mechanism of action

Drugs modulate these physiological parameters by targeting specific molecular entities such as the Na-K-2Cl cotransporter (NKCC2), sodium-chloride symporter (NCC), vasopressin V2 receptors, or the renin-angiotensin-aldosterone system (RAAS) to alter the renal handling of water and solutes (StatPearls, 2023, Physiology, Fluid Compartments).

03

Biological functions

HomeostasisOsmoregulationBlood pressure regulationTissue perfusionElectrolyte balance
04

Disease associations

HypertensionHeart failureHyponatremiaHypernatremiaEdemaDehydrationSyndrome of inappropriate antidiuretic hormone secretion (SIADH)Diabetes insipidusChronic kidney disease
05

Safety considerations

Electrolyte imbalances (e.g., hypokalemia, hyperkalemia)Orthostatic hypotensionAcute kidney injuryOsmotic demyelination syndrome (if hyponatremia is corrected too rapidly)Pulmonary edema (volume overload)
06

Interacting drugs

Furosemide

7 more in the full profile.

07

Biomarkers

Serum sodium concentrationPlasma osmolalityUrine specific gravityHematocritB-type natriuretic peptide (BNP)Blood urea nitrogen (BUN) to creatinine ratio

Beyond the preview

Go deeper on Extracellular fluid volume and osmolarity (ECFV/Osm).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular fluid volume and osmolarity (ECFV/Osm).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call